NewsAnne D Pham2022-04-06T14:56:51+00:00

Research News & Updates

ALSFAC funded investigators actively disseminate information around ALS clinical and scientific breakthroughs and challenges via print, TV, social media, and through public presentations.

Browse by year: 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015

ALS Finding a Cure and The ALS Association Partner to Reduce Time to Initial ALS Diagnosis
Gallery

ALS Finding a Cure and The ALS Association Partner to Reduce Time to Initial ALS Diagnosis

ALS Finding a Cure and The ALS Association Partner to Reduce Time to Initial ALS Diagnosis Organizations Commit $2M towards New International ALS Diagnostics Effort Boston, MA., Washington, [...]

ALS Finding a Cure Providing the Initial Funding for Amylyx
Gallery

ALS Finding a Cure Providing the Initial Funding for Amylyx

ALS Finding a Cure Providing the Initial Funding for Amylyx In every journey of discovery, certain days distinguish themselves as fundamental to achieving the ultimate objective. Yesterday was [...]

ALS Finding a Cure and The ALS Association Partner to Reduce Time to Initial ALS Diagnosis

Anne D Pham2023-08-16T14:46:48+00:00August 16th, 2023|

ALS Finding a Cure Providing the Initial Funding for Amylyx

Anne D Pham2022-10-03T00:59:42+00:00October 2nd, 2022|

Publications related to Answer ALS, a project ALS FAC helped fund

Anne D Pham2022-09-28T00:26:41+00:00September 28th, 2022|

Independent FDA Advisory Panel Recommends Approving ALS Drug

Anne D Pham2022-09-13T18:04:22+00:00September 8th, 2022|

Healey & AMG Center, ALS Finding a Cure® and FightMND announce the 2022 ALS Scholars in Therapeutics Recipients

Anne D Pham2022-08-25T12:23:38+00:00August 24th, 2022|

AI Finds Potential Drug Targets for Amyotrophic Lateral Sclerosis

Anne D Pham2022-07-07T19:45:26+00:00July 7th, 2022|

ALS Finding a Cure® funded Amylyx’s preclinical and early clinical work

Anne D Pham2022-06-15T18:43:49+00:00June 13th, 2022|

ALS Finding a Cure® funded the SOD1 1/2 life work used in the Tofersen study

Anne D Pham2022-06-15T18:44:53+00:00June 3rd, 2022|

ALS Finding a Cure® funded Eledon’s early clinical work for Tegoprubart when the drug was still with ALS TDI

Anne D Pham2022-06-15T18:44:42+00:00May 31st, 2022|

ALS Association Supports Study of SARM1 Variants

Anne D Pham2022-04-19T13:26:30+00:00April 19th, 2022|

Motor neuron toxin associated with ALS identified by UMass Chan investigators

Anne D Pham2022-04-06T14:45:26+00:00March 10th, 2022|

Cedars-Sinai receives $11.99 million from CIRM to launch ALS clinical trial

Anne D Pham2022-04-06T14:36:37+00:00June 23rd, 2021|

Healey Center for ALS in partnership with ALS Finding a Cure announces the 2021 ALS Scholars in Therapeutics Recipients

Anne D Pham2022-04-06T14:10:45+00:00June 21st, 2021|

ALSFAC-Funded Project Announces Successful ALS Clinical Trial and High-Profile Publication

Anne D Pham2021-09-07T16:20:37+00:00June 20th, 2021|

ALSFAC Funded Research Turns Off Key Gene in Families with ALS

Anne D Pham2021-09-07T16:20:37+00:00June 19th, 2021|

Team of Five Labs Launches Novel Attack on ALS

Anne D Pham2021-09-07T16:20:37+00:00June 18th, 2021|

Progress Coming in Amyotrophic Lateral Sclerosis, but Rigorous Studies Needed

Anne D Pham2021-09-07T16:20:37+00:00June 18th, 2021|

Johns Hopkins University, Cedars-Sinai and Massachusetts General Hospital Announce Groundbreaking ALS Research Project of Answer ALS

Anne D Pham2022-03-09T16:33:09+00:00June 18th, 2021|

Karyopharm Advancing Neuroprotective SINE™ Compounds in Amyotrophic Lateral Sclerosis (ALS)

Anne D Pham2021-09-07T16:20:38+00:00June 18th, 2021|

A loved one’s diagnosis moved this UCLA Health researcher to take on ALS

Anne D Pham2022-04-06T14:40:49+00:00May 11th, 2021|

Coya Raises $10M to Advance T-cell Therapy Now in Phase 2 ALS Trial

Anne D Pham2021-09-07T16:20:38+00:00March 5th, 2021|

Answer ALS Launches ‘The Data is Here’ Campaign to Announce the Release of the World’s Largest Open Sourced ALS Data Portal

Anne D Pham2021-09-07T16:20:38+00:00January 8th, 2021|

Multi-center, multi-tracer PET studies harmonized to detect neuroinflammation in ALS

Anne D Pham2021-09-07T16:21:02+00:00December 1st, 2020|

Novus Therapeutics Announces First Patient Enrolled in Phase 2a Clinical Trial of Anti-CD40L Antibody AT-1501 in Amyotrophic Lateral Sclerosis

Anne D Pham2021-09-07T16:21:02+00:00November 2nd, 2020|

Aural Analytics To Power Speech-Based Endpoints For The Healey Center ALS Platform Trial at Mass General Hospital

Anne D Pham2021-09-07T16:21:03+00:00August 6th, 2020|